Pol Tech
Pol Tech is a distinguished manufacturer specializing in cell therapy solutions, with a primary emphasis on skin rejuvenation through innovative cell therapy products. Our journey commenced with the development of an autologous cell therapy product, VanoCell, designed to harness the potential of fibroblasts to rejuvenate skin, particularly targeting scars and wrinkles. The essence of sustainability is inherently woven into the fabric of autologous cell therapy, as it minimizes the environmental footprint by utilizing the body’s own cells, thereby reducing the reliance on external materials or chemicals. Currently, VanoCell is undergoing rigorous clinical trials, and is on a promising trajectory to receive authorization for injection by early 2024. This endeavor is not only a reflection of Pol Tech’s commitment to advancing the frontier of skin care solutions through cell therapy but also embodies our dedication to sustainable practices. By amalgamating science with aesthetics, we aim to offer a new lease of life to skin, ensuring that the journey towards beauty and restoration is in harmony with environmental stewardship. As we meticulously progress through the clinical evaluation, we inch closer to offering a scientifically-backed, transformative, and sustainable solution for skin rejuvenation, underscoring Pol Tech’s dedication to marrying innovation with holistic and eco-conscious skin care.